PNC Financial Services Group’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.98K Buy
1,268
+1,227
+2,993% +$7.01K ﹤0.01% 4138
2026
Q1
$192 Sell
41
-33
-45% -$256 ﹤0.01% 5038
2025
Q4
$571 Buy
+74
New +$580 ﹤0.01% 4804

Other funds holding DERM

PNC Financial Services Group's DERM Position: Q2 2026 in Review

PNC Financial Services Group increased its Journey Medical (DERM) stake by 2,993% in Q2 2026, buying an estimated $7.01K and bringing the position to 1,268 shares worth $8.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4138.

PNC Financial Services Group first reported a position in DERM in Q4 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • PNC Financial Services Group held 1,268 shares of Journey Medical worth $8.98K as of Q2 2026.
  • PNC Financial Services Group bought 1,227 Journey Medical shares in Q2 2026, an estimated $7.01K.
  • Journey Medical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4138 holding.
  • PNC Financial Services Group first reported a position in Journey Medical in Q4 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.